Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

October 29, 2018 updated by: Tasly Pharmaceuticals, Inc.
This is a randomized, controlled, cross-over study on the effects of consumption of Deepure puerh tea extract (PTE) on glucose tolerance and metabolic markers.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The study will involve consuming three different doses: 1 gram, 1.5 grams, and 2 grams, and will be given in warm water, with a bland meal. The effects on glucose and insulin after consumption will be evaluated.The subjects will be randomly assigned to one of four groups with different sequences.

Study Type

Interventional

Enrollment (Anticipated)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Oregon
      • Klamath Falls, Oregon, United States, 97601
        • Recruiting
        • NIS Labs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women;
  • Aged 18-70 years;
  • BMI between 20-30;
  • Fasting blood glucose at screening between 71-125 mg/dL. both inclusive.

Exclusion Criteria:

  • Taking dietary supplements judged to interfere with the effects of Deepure on glucose metabolism (for example: cinnamon extract; chromium picolinate; mulberry extract; bitter melon extract, green tea extracts, black tea extracts, pu-erh tea);
  • Participation in other clinical trials, involving an investigational product or lifestyle change, during the last month;
  • Participation in another research study during this trial, involving an investigational product or lifestyle change; Taking prescription medication known to affect glucose metabolism;
  • Taking over-the-counter medication known to affect glucose metabolism;
  • Drinking 3 or more cups of tea daily;
  • Unwilling to abstain from drinking tea for 24 hours before clinic visits; (if a person drinks tea within 24 hours of a clinic visit, the person's visit will be re-scheduled);
  • Consuming 2 or more drinks of alcohol per day;
  • Unwilling to abstain from drinking alcohol for 10 hours before clinic visits;
  • Diagnosed with diabetes Type I; Taking medication for diabetes Type II;
  • Diagnosed with the thyroid disorder Hashimoto's disease;
  • Past major surgery to your stomach or intestines (minor surgery not a problem such as hernia repair, appendix removal, gallbladder removal);
  • Currently taking cholesterol-lowering medication (for example: statins);
  • Currently taking coumadin;
  • Major trauma within the past 6 months;
  • Major surgery within the past 6 months;
  • Severe chronic infectious disease (such as HIV, chronic hepatitis);
  • Active depression;
  • Self-reported eating disorders;
  • History of drug abuse during past two years;
  • Currently going through intense stressful events or life changes;
  • Women of child-bearing potential: Pregnant, breast-feeding, or trying to become pregnant;
  • Women of child-bearing potential: Not using effective contraception;
  • Food allergies or sensitivities to tea.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Deepure Group A
Visit 3: Warm water without Deepure; Visit 4: Warm water with 1 g Deepure; Visit 5: Warm water with 1.5 g Deepure; Visit 6: Warm water with 2 g Deepure.
Pu'erh Tea extract
EXPERIMENTAL: Deepure Group B
Visit 3: Warm water with 1 g Deepure; Visit 4: Warm water with 1.5 g Deepure; Visit 5: Warm water with 2 g Deepure; Visit 6: Warm water without Deepure.
Pu'erh Tea extract
EXPERIMENTAL: Deepure Group C
Visit 3: Warm water with 1.5 g Deepure; Visit 4: Warm water with 2 g Deepure; Visit 5: Warm water without Deepure; Visit 6: Warm water with 1 g Deepure.
Pu'erh Tea extract
EXPERIMENTAL: Deepure Group D
Visit 3: Warm water with 2 g Deepure; Visit 4: Warm water without Deepure; Visit 5: Warm water with 1 g Deepure; Visit 6: Warm water with 1.5 g Deepure.
Pu'erh Tea extract

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-prandial glucose response
Time Frame: From baseline to 30, 60, 90, 120, and 180 minutes
Change in blood glucose leve after consuming test meal with and without Pu'er tea
From baseline to 30, 60, 90, 120, and 180 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 20, 2018

Primary Completion (ANTICIPATED)

June 1, 2019

Study Completion (ANTICIPATED)

July 1, 2019

Study Registration Dates

First Submitted

July 26, 2018

First Submitted That Met QC Criteria

August 1, 2018

First Posted (ACTUAL)

August 3, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 31, 2018

Last Update Submitted That Met QC Criteria

October 29, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 079-007

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glucose Metabolism Disorders

3
Subscribe